期刊文献+

协同刺激分子B7-H3在结肠癌细胞株中的表达水平及其分布特征 被引量:1

The expression and subcellular distrubution of co-stimulatory molecule B7-H3 in colon cancer cell lines
下载PDF
导出
摘要 目的研究协同刺激分子B7-H3在结肠癌细胞株中的表达及其细胞内亚细胞结构的分布特征。方法分别采用Real-time PCR、Western Blot方法检测B7-H3在三株结肠癌细胞SW620、SW480、DLD-1中mRNA和蛋白质的表达水平;激光共聚焦显微镜观察B7-H3分子在三株结肠癌细胞中的亚细胞定位。结果 SW620、SW480、DLD-1 Real-time PCR的B7-H3 mRNA△Ct值分别为21.11±0.07、21.18±0.39、21.45±0.18,F=1.3497,P=0.309;Western Blot检测B7-H3蛋白的表达水平无明显差别;B7-H3分子细胞核内的表达比例分别为0.462±0.07、0.329±0.039、0.411±0.025。SW480细胞B7H3核内分布比例与另两株细胞有明显差异(P<0.05)。结论不同结肠癌细胞株中B7-H3 mRNA与蛋白的表达水平无明显差异,细胞核内有部分B7-H3分子表达,且不同细胞株之间B7-H3的核内表达有一定差异。 Objective To investigate the expression of co-stimulatory molecule B7-H3 in the three erlon cancer cells, as well as its subcellnlar distribution in these cells. Methods The Real-time PCR was used to detect the B7-H3 expres- sion in mRNA level, and Western Blot was applied to analyze B7-H3 expression in protein level. The subcellular distribution of B7-H3 was observed with confocal laser scanning microscope. Results The real-time PCR of BT-H3 mRNA were 21.11 ± 0. 07, 21.18± 0. 39, 21.45 _± 0. 18, F = 1. 3497, P= 0. 309, respectively ; and Western Blot results indicated that BT-H3 expression had no significant differences in protein levels. The results of confocal scanning showed the ratio of B7-H3 expressed in colon cancer cell nucleus were 0. 462 ±0. 07, 0. 329 ± 0. 039, 0.411 ± 0. 025. The nucleus distribu- tion of B7-H3 in SW480 was significantly different between SW620 and DLD-1 ( P 〈 0.05 ). Conclusion B7-H3 had a higher expression in colon cancer cell lines. Meanwhile, B7-H3 might play some functions in the nucleus of colon cancer cells.
出处 《癌症进展》 2012年第6期542-546,共5页 Oncology Progress
基金 江苏省自然科学基金(BK2012538)
关键词 B7-H3 结肠癌细胞 亚细胞定位 细胞核 B7-H3 colon cancer subcelluar location nucleus
  • 相关文献

参考文献11

  • 1Motilva V, Garcia-Maurino S, Talero E, et al. New para- digms in chronic intestinal inflammation and colon cancer: role of melatonin [J]. J Pineal Res, 2011,51 (1):44 - 60.
  • 2Sharpe AH, Freeman GJ. The B7-CD28 superfamily [ R]. Nat Rev Immunol, 2002, 2 (2):116 -126.
  • 3Chapoval AI, Ni J, Lau JS, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-/ production [ J ]. Nat Immunol, 2001, 2 (3): 269 -274.
  • 4Ingebrigtsen VA, Boye K, Tekle C, et al. BT-H3 expres- sion in colorectal cancer: Nuclear localization strongly pre- dicts poor outcome in colon cancer. International journal of cancer [J]. Int J Cancer 2012, 131 (11): 2528 -2536.
  • 5Yi KH, Chen L. Fine tuning the immune response through B7-H3 and B7-H4 [J]. Immunol Rev, 2009, 229 ( 1 ) : 145 - 151.
  • 6Loos M, Hedderich DM, Friess H, et al. B7-h3 and its role in antitumor immunity [ J ]. Clin Dev Immunol,2010: 683875.
  • 7Sun J, Chen LJ, Zhang GB, et el. Clinical significance and regulation of the costiroulatory molecule BT-H3 in hu- man colorectal carcinoma [ J ]. Cancer Immunol, immu- nother, 2010, 59 (8) : 1163 - 1171.
  • 8Xu H, Cheung IY, Guo HF, et al. MicroRNA miR-29 modulates expression of irorounoinhibitory molecule B7-H3 : potential implications for iromune hosed therapy of huroan solid tumors I J], Cancer ltea, 2009, 69 (15) : 6275 - 6281.
  • 9Liu M, Chen H, The role of microRNAs in colorectal canc- er [ J]. J Genet Genoroicm, 2010, 37 (6) : 347 - 358.
  • 10Schroitt M J, Margue C, Behrmann I, et al. miRNA-29 : A microRNA Family with Tumor-Suppressing and Iromune- Modulating Properties [J]. Curr Mol Med, 2012.

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部